Commentary

The Hatch-Waxman Act kept drug prices in line for years, but over time, Big Pharma learned how to game the law.

Benefits brokers weigh in on the legislative trends currently on their radar. Are you in the know?

"The Face of Change" is not just the title of a column or a session, but an actual movement in our industry.

True, Wisconsin government employees and retirees are more exposed to investment risks than participants in traditional defined-benefit pensions.

By overriding patents for opioid antidotes, the government could lower the costs and increase availability of the life-saving drugs.

These 3 errors can lead to employees losing retirement savings rather than being as prepared as they'd planned.